RIM
EXAS

Rockbridge Investment Management’s Exact Sciences EXAS Stock Holding History

Rockbridge Investment Management’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-200
Closed -$14.8K – 288
2023
Q4 		$14.8K Buy
+200
New +$13.1K ﹤0.01% 360
2022
Q3 		– Sell
-24
Closed -$946 – 272
2022
Q2 		$946 Hold
24
– – ﹤0.01% 578
2022
Q1 		$1.81K Hold
24
– – ﹤0.01% 705
2021
Q4 		$2K Hold
24
– – ﹤0.01% 723
2021
Q3 		$2K Hold
24
– – ﹤0.01% 671
2021
Q2 		$3K Hold
24
– – ﹤0.01% 641
2021
Q1 		$3K Sell
24
-11
-31% -$1.51K ﹤0.01% 615
2020
Q4 		$5K Hold
35
– – ﹤0.01% 561
2020
Q3 		$4K Hold
35
– – ﹤0.01% 538
2020
Q2 		$3K Buy
+35
New +$2.8K ﹤0.01% 529

Other funds holding EXAS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Rockbridge Investment Management's EXAS Position: Q1 2024 in Review

Rockbridge Investment Management sold out of Exact Sciences (EXAS) in Q1 2024, closing a stake of 200 shares — an estimated $14.8K sold.

Rockbridge Investment Management first reported a position in EXAS in Q2 2020 and held it in 10 quarters. The position peaked at $14.8K in Q4 2023. 627 funds tracked by Wall St. Rank hold EXAS as of Q1 2024.

  • Rockbridge Investment Management reported no remaining Exact Sciences position as of Q1 2024 after selling out during the quarter.
  • Rockbridge Investment Management sold 200 Exact Sciences shares in Q1 2024, an estimated $14.8K.
  • Rockbridge Investment Management first reported a position in Exact Sciences in Q2 2020 and held it in 10 quarters.
  • Rockbridge Investment Management's Exact Sciences position peaked at $14.8K in Q4 2023.
  • 627 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2024.

Based on Rockbridge Investment Management's 13F filing for Q1 2024, filed 15 May 2024.